Evidence map›Paper›PMID 24606807›Full record

ArticleActa neuropathologica communications2014

α4-integrins control viral meningoencephalitis through differential recruitment of T helper cell subsets.

Veit Rothhammer, Andreas Muschaweckh, Georg Gasteiger, Franziska Petermann, Sylvia Heink, Dirk H Busch, Mathias Heikenwälder, Bernhard Hemmer, Ingo Drexler, Thomas Korn

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Ena/VASP proteins regulate activated T-cell trafficking by promoting diapedesis during transendothelial migration.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  9. T cell responses in the central nervous system.Nature reviews. Immunology · 2017
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Veit Rothhammer
Andreas Muschaweckh
Georg Gasteiger
Franziska Petermann
Sylvia Heink
Dirk H Busch
Mathias Heikenwälder
Bernhard Hemmer
Ingo Drexler
Thomas KornKlinikum rechts der Isar, Department of Neurology, Technische Universität München, Ismaninger Str, 22, 81675 Munich, Germany. korn@lrz.tum.de.
TUM Klinikum · DEHelmholtz Zentrum München · DEDüsseldorf University Hospital · DEInstitute of Medical Microbiology and Hygiene · DEMemorial Sloan Kettering Cancer Center · USMunich Cluster for Systems Neurology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNatalizumab blocks α4-integrins and is a prototypic agent for a series of anti-inflammatory drugs that impair trafficking of immune cells into the CNS. However, modulation of the access of immune cells to the CNS is associated with impaired immune surveillance and detrimental viral infections of the CNS. Here, we explored the potency of cellular immune responses within the CNS to protect against viral encephalitis in mice with T cell conditional disruption of VLA-4 integrin (α4β1) expression.

resultsWhile VLA-4 expression in virus specific Th1 cells is non-redundant for their ability to access the CNS, α4-integrin deficient Th17 cells enter the CNS compartment and generate an inflammatory milieu upon intrathecal vaccinia virus (VV) infection. However, in contrast to Th1 cells that can adopt direct cytotoxic properties, Th17 cells fail to clear the virus due to insufficient Eomes induced perforin-1 expression.

conclusionThe quality of the intrathecal cellular antiviral response under conditions of impaired VLA-4 function jeopardizes host protection. Our functional in vivo data extend our mechanistic understanding of anti-viral immunity in the CNS and help to estimate the risk potential of upcoming therapeutic agents that target the trafficking of immune cells into distinct anatomical compartments.

Indexed as

Adoptive TransferAnimalsAntibodiesCD4 AntigensCell DifferentiationCytokinesDisease Models, AnimalForkhead Transcription FactorsFreund's AdjuvantGene Expression Regulation, ViralHomeodomain ProteinsIntegrin alpha4beta1MeningoencephalitisMiceMice, Inbred C57BLMice, TransgenicAntibodiesCD4 AntigensCytokinesForkhead Transcription FactorsFoxp3 protein, mouseFreund's AdjuvantHomeodomain ProteinsIntegrin alpha4beta1Perforinperforin 1, mousePore Forming Cytotoxic ProteinsRAG-1 protein

Identifiers

PMID24606807
PMCPMC4029267
OpenAlexW2160002783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.